American Journal of Cardiovascular Drugs

Pharmacologic Treatment of Heart Failure due to Ventricular Dysfunction by Myocardial Stunning: Potential Role of Levosimendan
pp. 69-75(7)
Authors: González, Martín J. García; Rodríguez, Alberto Domínguez

Mechanisms, Manifestations, and Management of Digoxin Toxicity in the Modern Era
pp. 77-86(10)
Authors: Bauman, Jerry L.; DiDomenico, Robert J.; Galanter, William L.

Preventing Cardiovascular Disease in the 21st Century: Therapeutic and Preventive Implications of Current Evidence
pp. 87-101(15)
Authors: Daviglus, Martha L.; Lloyd-Jones, Donald M.; Pirzada, Amber

A Review of the Efficacy of Fixed-Dose Combinations Olmesartan Medoxomil/Hydrochlorothiazide and Amlodipine Besylate/Benazepril in Factorial Design Studies
pp. 103-113(11)
Authors: Quan, Allen; Chavanu, Kathleen; Merkel, Jennifer

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function
pp. 115-120(6)
Author: Tesfamariam, Belay

Lipid Management and Cholesterol Goal Attainment in Norway
pp. 121-128(8)
Authors: Ose, Leiv; Skjeldestad, Finn E.; Bakken, Inger J.; Levorsen, Andrée; Alemao, Evo A.; Yin, Don D.; Borgström, Fredrik; Jönsson, Linus

Cost Effectiveness of Biventricular Pacemakers in Heart Failure Patients
pp. 129-137(9)
Authors: Heerey, Adrienne; Lauer, Michael; AlSolaiman, Firas; Czerr, Jennifer; James, Karen